Point72 Europe (London) LLP Axsome Therapeutics, Inc. Transaction History
Point72 Europe (London) LLP
- $1.62 Billion
- Q4 2024
A detailed history of Point72 Europe (London) LLP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 41,734 shares of AXSM stock, worth $5.75 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
41,734
Previous 34,570
20.72%
Holding current value
$5.75 Million
Previous $3.11 Million
13.68%
% of portfolio
0.22%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$558 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$455 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$202 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$191 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.91B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...